Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 77 | 2024 | 3233 | 4.760 |
Why?
|
Heart-Assist Devices | 40 | 2023 | 1286 | 4.600 |
Why?
|
Heart Diseases | 24 | 2024 | 2785 | 4.170 |
Why?
|
Palliative Care | 15 | 2023 | 3585 | 1.630 |
Why?
|
Cardiology | 9 | 2024 | 1668 | 1.560 |
Why?
|
Heart Failure | 44 | 2023 | 11653 | 1.420 |
Why?
|
Heart Defects, Congenital | 23 | 2024 | 4692 | 1.420 |
Why?
|
Parents | 14 | 2023 | 3563 | 1.330 |
Why?
|
Terminal Care | 9 | 2022 | 1751 | 1.310 |
Why?
|
Waiting Lists | 17 | 2022 | 765 | 1.230 |
Why?
|
Graft Rejection | 25 | 2024 | 4438 | 1.120 |
Why?
|
Pediatrics | 7 | 2024 | 3593 | 1.090 |
Why?
|
Physicians | 7 | 2022 | 4586 | 1.090 |
Why?
|
Child | 114 | 2024 | 80086 | 0.990 |
Why?
|
Child, Preschool | 79 | 2024 | 42209 | 0.910 |
Why?
|
Infant | 73 | 2024 | 36183 | 0.860 |
Why?
|
Cost of Illness | 2 | 2023 | 1931 | 0.820 |
Why?
|
Attitude to Death | 3 | 2023 | 399 | 0.800 |
Why?
|
Registries | 24 | 2021 | 8216 | 0.750 |
Why?
|
Tissue Donors | 8 | 2022 | 2319 | 0.750 |
Why?
|
Fathers | 1 | 2024 | 376 | 0.730 |
Why?
|
Child, Hospitalized | 4 | 2024 | 182 | 0.710 |
Why?
|
Organ Transplantation | 4 | 2021 | 1154 | 0.710 |
Why?
|
Quality of Life | 10 | 2023 | 13338 | 0.690 |
Why?
|
Withholding Treatment | 3 | 2021 | 617 | 0.690 |
Why?
|
Cardiomyopathy, Dilated | 7 | 2017 | 819 | 0.670 |
Why?
|
Professional-Family Relations | 2 | 2021 | 495 | 0.640 |
Why?
|
Fontan Procedure | 9 | 2017 | 796 | 0.620 |
Why?
|
Adolescent | 81 | 2024 | 88196 | 0.610 |
Why?
|
Attitude of Health Personnel | 4 | 2021 | 3880 | 0.570 |
Why?
|
Job Satisfaction | 1 | 2021 | 544 | 0.560 |
Why?
|
Heart, Artificial | 1 | 2017 | 107 | 0.550 |
Why?
|
Ventricular Function | 4 | 2012 | 406 | 0.520 |
Why?
|
Dyslipidemias | 1 | 2022 | 868 | 0.470 |
Why?
|
Bronchitis | 2 | 2014 | 196 | 0.460 |
Why?
|
Infant, Newborn | 34 | 2024 | 26280 | 0.450 |
Why?
|
Graft Survival | 10 | 2024 | 3806 | 0.440 |
Why?
|
Bereavement | 2 | 2014 | 308 | 0.440 |
Why?
|
Transplantation | 2 | 2012 | 219 | 0.440 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2013 | 321 | 0.430 |
Why?
|
Humans | 162 | 2024 | 760437 | 0.420 |
Why?
|
Echocardiography, Stress | 2 | 2022 | 134 | 0.420 |
Why?
|
Terminally Ill | 1 | 2014 | 240 | 0.410 |
Why?
|
Burnout, Professional | 1 | 2021 | 704 | 0.400 |
Why?
|
Propanolamines | 4 | 2010 | 163 | 0.390 |
Why?
|
Patient Care Team | 4 | 2021 | 2517 | 0.390 |
Why?
|
Male | 101 | 2024 | 360035 | 0.380 |
Why?
|
HLA Antigens | 4 | 2018 | 1371 | 0.380 |
Why?
|
Product Surveillance, Postmarketing | 5 | 2012 | 452 | 0.380 |
Why?
|
Prognosis | 12 | 2024 | 29551 | 0.380 |
Why?
|
Transposition of Great Vessels | 4 | 2021 | 593 | 0.380 |
Why?
|
Referral and Consultation | 3 | 2021 | 3596 | 0.370 |
Why?
|
Carbazoles | 4 | 2010 | 220 | 0.360 |
Why?
|
6-Ketoprostaglandin F1 alpha | 2 | 2002 | 80 | 0.360 |
Why?
|
Hospital Mortality | 5 | 2021 | 5283 | 0.360 |
Why?
|
Female | 100 | 2024 | 391875 | 0.350 |
Why?
|
American Heart Association | 4 | 2023 | 1045 | 0.350 |
Why?
|
Cardiomyopathies | 8 | 2024 | 1957 | 0.350 |
Why?
|
Adrenergic beta-Antagonists | 5 | 2014 | 1240 | 0.350 |
Why?
|
Isoantibodies | 3 | 2018 | 674 | 0.350 |
Why?
|
Extracorporeal Membrane Oxygenation | 7 | 2020 | 1460 | 0.340 |
Why?
|
Survival Rate | 22 | 2020 | 12698 | 0.340 |
Why?
|
Death | 5 | 2023 | 676 | 0.340 |
Why?
|
Treatment Outcome | 37 | 2024 | 64591 | 0.330 |
Why?
|
Exercise Test | 3 | 2013 | 2127 | 0.330 |
Why?
|
Postoperative Complications | 16 | 2024 | 15627 | 0.330 |
Why?
|
Tacrolimus | 4 | 2023 | 733 | 0.330 |
Why?
|
Retrospective Studies | 45 | 2024 | 80430 | 0.320 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2020 | 2117 | 0.310 |
Why?
|
United States Food and Drug Administration | 5 | 2014 | 1663 | 0.310 |
Why?
|
Echocardiography, Doppler | 4 | 2020 | 898 | 0.310 |
Why?
|
Databases, Factual | 11 | 2017 | 7948 | 0.310 |
Why?
|
Cross-Sectional Studies | 12 | 2024 | 26063 | 0.300 |
Why?
|
Friedreich Ataxia | 1 | 2008 | 77 | 0.300 |
Why?
|
Social Class | 3 | 2024 | 2003 | 0.290 |
Why?
|
Immunosuppressive Agents | 6 | 2023 | 4168 | 0.290 |
Why?
|
United States | 34 | 2023 | 72202 | 0.290 |
Why?
|
Antibodies | 2 | 2023 | 2421 | 0.280 |
Why?
|
Stroke Volume | 4 | 2014 | 5487 | 0.260 |
Why?
|
Intensive Care Units | 1 | 2019 | 3742 | 0.260 |
Why?
|
Young Adult | 28 | 2023 | 59068 | 0.240 |
Why?
|
Physical Exertion | 1 | 2007 | 666 | 0.240 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2021 | 4569 | 0.230 |
Why?
|
Risk Factors | 30 | 2024 | 74055 | 0.220 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 2002 | 318 | 0.220 |
Why?
|
Double Outlet Right Ventricle | 2 | 2002 | 60 | 0.210 |
Why?
|
Clinical Competence | 2 | 2024 | 4777 | 0.210 |
Why?
|
Autonomic Nervous System | 1 | 2007 | 701 | 0.200 |
Why?
|
Adult | 34 | 2024 | 220781 | 0.200 |
Why?
|
Hospitals, Pediatric | 6 | 2021 | 1859 | 0.200 |
Why?
|
Follow-Up Studies | 27 | 2024 | 39078 | 0.200 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6388 | 0.190 |
Why?
|
Family Relations | 1 | 2004 | 317 | 0.190 |
Why?
|
Longitudinal Studies | 7 | 2023 | 14565 | 0.190 |
Why?
|
Atrial Flutter | 1 | 2003 | 252 | 0.190 |
Why?
|
Tachycardia | 1 | 2003 | 600 | 0.190 |
Why?
|
Device Approval | 2 | 2012 | 163 | 0.180 |
Why?
|
Annual Reports as Topic | 2 | 2017 | 36 | 0.180 |
Why?
|
Family Health | 2 | 2021 | 1257 | 0.180 |
Why?
|
Pilot Projects | 4 | 2024 | 8611 | 0.180 |
Why?
|
Heart | 5 | 2023 | 4391 | 0.180 |
Why?
|
Cause of Death | 6 | 2021 | 3686 | 0.180 |
Why?
|
Endothelium, Vascular | 3 | 2002 | 4430 | 0.170 |
Why?
|
Isoenzymes | 2 | 2002 | 1688 | 0.170 |
Why?
|
Hemophilia A | 1 | 2003 | 360 | 0.170 |
Why?
|
Time Factors | 19 | 2021 | 39947 | 0.170 |
Why?
|
Coronary Care Units | 1 | 2021 | 235 | 0.170 |
Why?
|
Prospective Studies | 15 | 2022 | 54339 | 0.160 |
Why?
|
Antilymphocyte Serum | 2 | 2019 | 483 | 0.160 |
Why?
|
Informed Consent By Minors | 1 | 2019 | 9 | 0.160 |
Why?
|
Cell Hypoxia | 1 | 2002 | 656 | 0.160 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2008 | 1313 | 0.160 |
Why?
|
Hospital Charges | 1 | 2021 | 351 | 0.160 |
Why?
|
Receptors, Prostaglandin | 1 | 1998 | 53 | 0.160 |
Why?
|
Psychological Tests | 1 | 2021 | 640 | 0.160 |
Why?
|
Hospitalization | 3 | 2024 | 10698 | 0.160 |
Why?
|
Father-Child Relations | 1 | 2019 | 48 | 0.160 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2021 | 491 | 0.160 |
Why?
|
Feasibility Studies | 3 | 2023 | 5236 | 0.150 |
Why?
|
Epithelial Cells | 2 | 2002 | 3661 | 0.150 |
Why?
|
Patient Selection | 4 | 2021 | 4240 | 0.150 |
Why?
|
Pulsatile Flow | 2 | 2016 | 321 | 0.150 |
Why?
|
Heart Murmurs | 1 | 1998 | 93 | 0.150 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2018 | 100 | 0.150 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2017 | 39 | 0.150 |
Why?
|
Pacemaker, Artificial | 1 | 2003 | 808 | 0.150 |
Why?
|
Digestive System Abnormalities | 1 | 2017 | 49 | 0.150 |
Why?
|
Selectins | 1 | 1997 | 101 | 0.150 |
Why?
|
Pulmonary Valve | 1 | 2021 | 412 | 0.140 |
Why?
|
Heart Ventricles | 3 | 2016 | 3815 | 0.140 |
Why?
|
Mycophenolic Acid | 1 | 2019 | 347 | 0.140 |
Why?
|
Aortic Valve Insufficiency | 1 | 2021 | 579 | 0.140 |
Why?
|
Preoperative Period | 2 | 2017 | 550 | 0.140 |
Why?
|
Paracrine Communication | 1 | 1998 | 276 | 0.140 |
Why?
|
Risk Assessment | 11 | 2019 | 23953 | 0.140 |
Why?
|
Boston | 5 | 2024 | 9326 | 0.130 |
Why?
|
Body Surface Area | 1 | 2016 | 197 | 0.130 |
Why?
|
Heart Rate | 1 | 2007 | 4190 | 0.130 |
Why?
|
Severity of Illness Index | 7 | 2021 | 15820 | 0.130 |
Why?
|
Chlorides | 1 | 1998 | 665 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 7 | 2015 | 6471 | 0.130 |
Why?
|
Coronary Angiography | 4 | 2022 | 4468 | 0.130 |
Why?
|
International Cooperation | 2 | 2019 | 1428 | 0.130 |
Why?
|
Decision Making | 2 | 2019 | 3923 | 0.120 |
Why?
|
Fellowships and Scholarships | 2 | 2024 | 1117 | 0.120 |
Why?
|
Myocarditis | 3 | 2016 | 770 | 0.120 |
Why?
|
Hemodynamics | 4 | 2014 | 4167 | 0.120 |
Why?
|
Communication | 3 | 2024 | 3868 | 0.120 |
Why?
|
Tissue and Organ Procurement | 2 | 2022 | 950 | 0.120 |
Why?
|
Longevity | 1 | 2023 | 1062 | 0.120 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1997 | 691 | 0.120 |
Why?
|
Cardiac Care Facilities | 1 | 2014 | 34 | 0.120 |
Why?
|
Echocardiography | 4 | 2020 | 4981 | 0.120 |
Why?
|
Social Support | 2 | 2019 | 2167 | 0.120 |
Why?
|
Lymphoproliferative Disorders | 2 | 2010 | 533 | 0.120 |
Why?
|
Receptors, Adrenergic | 1 | 2014 | 155 | 0.120 |
Why?
|
Ascites | 2 | 2014 | 338 | 0.120 |
Why?
|
Health Education | 1 | 2021 | 1052 | 0.110 |
Why?
|
Cardiopulmonary Bypass | 2 | 2006 | 1094 | 0.110 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1997 | 1125 | 0.110 |
Why?
|
Cardiovascular Surgical Procedures | 2 | 2012 | 189 | 0.110 |
Why?
|
Survival Analysis | 7 | 2024 | 10075 | 0.110 |
Why?
|
Body Size | 1 | 2016 | 463 | 0.110 |
Why?
|
Abnormalities, Multiple | 2 | 2017 | 1422 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2002 | 1197 | 0.110 |
Why?
|
Lung Transplantation | 1 | 2023 | 1308 | 0.110 |
Why?
|
Chest Tubes | 1 | 2014 | 152 | 0.110 |
Why?
|
Family | 2 | 2022 | 3189 | 0.110 |
Why?
|
Chylothorax | 1 | 2014 | 83 | 0.110 |
Why?
|
Arrhythmias, Cardiac | 4 | 2019 | 2248 | 0.110 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2011 | 594 | 0.110 |
Why?
|
Michigan | 1 | 2014 | 339 | 0.110 |
Why?
|
Canada | 1 | 2019 | 2119 | 0.110 |
Why?
|
Myocardium | 6 | 2020 | 4700 | 0.110 |
Why?
|
Survivors | 1 | 2004 | 2369 | 0.110 |
Why?
|
Thrombocytopenia | 2 | 2014 | 1174 | 0.110 |
Why?
|
Pain | 2 | 2021 | 5075 | 0.110 |
Why?
|
Adaptation, Psychological | 1 | 2004 | 2629 | 0.110 |
Why?
|
Transplantation Tolerance | 1 | 2018 | 605 | 0.110 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2014 | 147 | 0.110 |
Why?
|
Self Report | 2 | 2022 | 3721 | 0.110 |
Why?
|
Internet | 2 | 2019 | 3092 | 0.100 |
Why?
|
Coronary Circulation | 3 | 2008 | 1565 | 0.100 |
Why?
|
Thoracic Surgery | 1 | 2019 | 722 | 0.100 |
Why?
|
Histocompatibility Testing | 3 | 2018 | 719 | 0.100 |
Why?
|
Advance Care Planning | 1 | 2019 | 694 | 0.100 |
Why?
|
Poverty | 1 | 2023 | 2694 | 0.100 |
Why?
|
Aorta, Thoracic | 1 | 1998 | 1097 | 0.100 |
Why?
|
Disease Progression | 4 | 2021 | 13484 | 0.100 |
Why?
|
Consensus | 1 | 2021 | 3115 | 0.090 |
Why?
|
Physician-Patient Relations | 1 | 2024 | 3246 | 0.090 |
Why?
|
Data Mining | 1 | 2016 | 551 | 0.090 |
Why?
|
Health Surveys | 1 | 2021 | 4056 | 0.090 |
Why?
|
Fear | 1 | 2019 | 1471 | 0.090 |
Why?
|
Pulmonary Artery | 2 | 2007 | 1938 | 0.090 |
Why?
|
Program Development | 1 | 2017 | 1297 | 0.090 |
Why?
|
Equipment Design | 3 | 2014 | 3510 | 0.090 |
Why?
|
ABO Blood-Group System | 2 | 2010 | 380 | 0.090 |
Why?
|
Cohort Studies | 12 | 2020 | 41366 | 0.090 |
Why?
|
Patient Participation | 1 | 2019 | 1442 | 0.090 |
Why?
|
Ventricular Dysfunction | 2 | 2009 | 144 | 0.090 |
Why?
|
Protein-Losing Enteropathies | 3 | 2009 | 45 | 0.090 |
Why?
|
Biopsy | 6 | 2020 | 6765 | 0.080 |
Why?
|
Chronic Disease | 2 | 2023 | 9309 | 0.080 |
Why?
|
Mental Health | 1 | 2004 | 3241 | 0.080 |
Why?
|
Transplantation, Homologous | 5 | 2020 | 4808 | 0.080 |
Why?
|
Neutropenia | 1 | 2014 | 884 | 0.080 |
Why?
|
Nurses | 1 | 2019 | 2471 | 0.080 |
Why?
|
Recovery of Function | 2 | 2011 | 2975 | 0.080 |
Why?
|
Histocompatibility | 1 | 2010 | 317 | 0.080 |
Why?
|
Incidence | 11 | 2018 | 21322 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2013 | 664 | 0.080 |
Why?
|
Middle Aged | 10 | 2021 | 220382 | 0.080 |
Why?
|
Drainage | 1 | 2014 | 1155 | 0.080 |
Why?
|
Cyclooxygenase 2 | 2 | 2002 | 597 | 0.070 |
Why?
|
Coronary Vessel Anomalies | 2 | 2002 | 308 | 0.070 |
Why?
|
Opportunistic Infections | 1 | 2010 | 376 | 0.070 |
Why?
|
Sudden Infant Death | 1 | 2010 | 291 | 0.070 |
Why?
|
Length of Stay | 1 | 2021 | 6413 | 0.070 |
Why?
|
Preoperative Care | 2 | 2019 | 2242 | 0.070 |
Why?
|
Mycoses | 1 | 2010 | 386 | 0.070 |
Why?
|
Nursing | 1 | 2007 | 35 | 0.070 |
Why?
|
Predictive Value of Tests | 6 | 2016 | 15257 | 0.070 |
Why?
|
Fatigue | 1 | 2014 | 1550 | 0.070 |
Why?
|
Death, Sudden, Cardiac | 2 | 2012 | 1554 | 0.070 |
Why?
|
Cardiac Output, Low | 1 | 2007 | 191 | 0.070 |
Why?
|
Critical Care | 1 | 2019 | 2697 | 0.070 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2008 | 223 | 0.070 |
Why?
|
Coculture Techniques | 2 | 2002 | 1340 | 0.070 |
Why?
|
Age Factors | 9 | 2019 | 18379 | 0.070 |
Why?
|
Dyspnea | 1 | 2014 | 1344 | 0.070 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2019 | 273 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8522 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 3486 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2014 | 1588 | 0.060 |
Why?
|
Multivariate Analysis | 7 | 2015 | 12054 | 0.060 |
Why?
|
Cardiovascular System | 1 | 2012 | 835 | 0.060 |
Why?
|
Proportional Hazards Models | 7 | 2016 | 12429 | 0.060 |
Why?
|
Treatment Failure | 5 | 2010 | 2642 | 0.060 |
Why?
|
Socioeconomic Factors | 3 | 2009 | 7817 | 0.060 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2022 | 1017 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2003 | 5126 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2010 | 1715 | 0.060 |
Why?
|
DNA Primers | 2 | 2014 | 2820 | 0.060 |
Why?
|
North America | 1 | 2008 | 1275 | 0.060 |
Why?
|
Cytomegalovirus Infections | 1 | 2010 | 831 | 0.060 |
Why?
|
Mutation, Missense | 3 | 2017 | 2571 | 0.060 |
Why?
|
Transplantation Conditioning | 1 | 2010 | 1588 | 0.060 |
Why?
|
Thromboxane-A Synthase | 1 | 1983 | 34 | 0.060 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 1 | 1983 | 27 | 0.060 |
Why?
|
Whole Blood Coagulation Time | 1 | 2003 | 30 | 0.050 |
Why?
|
Blood Urea Nitrogen | 1 | 2003 | 186 | 0.050 |
Why?
|
Acrylates | 1 | 1983 | 79 | 0.050 |
Why?
|
Parkinson Disease, Secondary | 1 | 1983 | 122 | 0.050 |
Why?
|
Sequence Deletion | 2 | 2014 | 1494 | 0.050 |
Why?
|
Methacrylates | 1 | 1983 | 109 | 0.050 |
Why?
|
Electrocardiography | 2 | 2008 | 6380 | 0.050 |
Why?
|
Premenstrual Syndrome | 1 | 1983 | 109 | 0.050 |
Why?
|
Endocardium | 2 | 2016 | 248 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 2 | 2011 | 3629 | 0.050 |
Why?
|
Bacterial Infections | 1 | 2010 | 1406 | 0.050 |
Why?
|
Research Design | 1 | 2018 | 6168 | 0.050 |
Why?
|
Peritoneal Dialysis | 1 | 1983 | 159 | 0.050 |
Why?
|
Coronary Disease | 1 | 2016 | 5919 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7531 | 0.050 |
Why?
|
Growth | 1 | 2003 | 365 | 0.050 |
Why?
|
Odds Ratio | 1 | 2014 | 9639 | 0.050 |
Why?
|
Aspartate Aminotransferases | 1 | 2003 | 417 | 0.050 |
Why?
|
Amnesia | 1 | 1983 | 255 | 0.050 |
Why?
|
Enzyme Induction | 1 | 2002 | 451 | 0.050 |
Why?
|
Ultrasonic Therapy | 1 | 1983 | 215 | 0.050 |
Why?
|
Clothing | 1 | 2021 | 97 | 0.050 |
Why?
|
Umbilical Veins | 1 | 2002 | 426 | 0.050 |
Why?
|
Hemorrhage | 3 | 2016 | 3414 | 0.050 |
Why?
|
Cardiotonic Agents | 2 | 2016 | 539 | 0.050 |
Why?
|
Health Services for the Aged | 1 | 1983 | 259 | 0.050 |
Why?
|
Factor VIII | 1 | 2003 | 349 | 0.050 |
Why?
|
Oxidoreductases | 1 | 1983 | 412 | 0.050 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2001 | 174 | 0.050 |
Why?
|
Common Variable Immunodeficiency | 1 | 2002 | 102 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2010 | 1874 | 0.050 |
Why?
|
ROC Curve | 2 | 2020 | 3571 | 0.040 |
Why?
|
Myocardial Ischemia | 1 | 2011 | 2110 | 0.040 |
Why?
|
Minority Groups | 2 | 2023 | 1201 | 0.040 |
Why?
|
Biomedical Research | 1 | 2016 | 3421 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2003 | 606 | 0.040 |
Why?
|
Dilatation | 1 | 2021 | 307 | 0.040 |
Why?
|
Urothelium | 1 | 2002 | 269 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 1983 | 694 | 0.040 |
Why?
|
Salvage Therapy | 1 | 2006 | 1264 | 0.040 |
Why?
|
Cyanosis | 1 | 1999 | 86 | 0.040 |
Why?
|
Prosthesis Design | 3 | 2012 | 2115 | 0.040 |
Why?
|
Obesity | 1 | 2022 | 12918 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14661 | 0.040 |
Why?
|
Logistic Models | 1 | 2014 | 13240 | 0.040 |
Why?
|
Heparin | 1 | 2006 | 1633 | 0.040 |
Why?
|
Anticoagulants | 2 | 2023 | 4806 | 0.040 |
Why?
|
Urinary Incontinence | 1 | 1983 | 489 | 0.040 |
Why?
|
Exercise | 2 | 2007 | 5874 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2014 | 4316 | 0.040 |
Why?
|
Vena Cava, Superior | 1 | 1999 | 198 | 0.040 |
Why?
|
Kidney Calculi | 1 | 1983 | 463 | 0.040 |
Why?
|
Genotype | 2 | 2014 | 12976 | 0.040 |
Why?
|
Reoperation | 2 | 2024 | 4300 | 0.040 |
Why?
|
Respiration, Artificial | 4 | 2011 | 2622 | 0.040 |
Why?
|
Respiratory Mucosa | 1 | 2002 | 439 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 928 | 0.040 |
Why?
|
Oligosaccharides | 1 | 2000 | 406 | 0.040 |
Why?
|
Carbachol | 1 | 1998 | 223 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 2217 | 0.040 |
Why?
|
Societies, Medical | 2 | 2021 | 3904 | 0.040 |
Why?
|
Policy | 1 | 2022 | 508 | 0.040 |
Why?
|
Sodium Channels | 1 | 1999 | 343 | 0.040 |
Why?
|
Renal Insufficiency | 2 | 2016 | 809 | 0.040 |
Why?
|
Base Sequence | 2 | 2014 | 12449 | 0.040 |
Why?
|
Epoprostenol | 1 | 1998 | 246 | 0.040 |
Why?
|
Prostaglandins | 1 | 1998 | 398 | 0.040 |
Why?
|
Creatinine | 1 | 2003 | 1898 | 0.040 |
Why?
|
Aged | 6 | 2021 | 168840 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 1998 | 522 | 0.040 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2000 | 480 | 0.030 |
Why?
|
Failure to Thrive | 1 | 2017 | 140 | 0.030 |
Why?
|
Multicenter Studies as Topic | 2 | 2013 | 1703 | 0.030 |
Why?
|
Arteries | 1 | 2021 | 1125 | 0.030 |
Why?
|
Vasodilation | 1 | 2000 | 961 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2014 | 22097 | 0.030 |
Why?
|
Cell Polarity | 1 | 1998 | 637 | 0.030 |
Why?
|
Long QT Syndrome | 1 | 1999 | 468 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 1983 | 1087 | 0.030 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2014 | 51 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9176 | 0.030 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2014 | 69 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1998 | 1250 | 0.030 |
Why?
|
Medical Record Linkage | 1 | 2016 | 285 | 0.030 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 322 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22083 | 0.030 |
Why?
|
Equipment Failure | 1 | 2016 | 578 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5105 | 0.030 |
Why?
|
Ventricular Pressure | 1 | 2014 | 210 | 0.030 |
Why?
|
Memory | 1 | 1983 | 2182 | 0.030 |
Why?
|
Extracorporeal Circulation | 1 | 2014 | 182 | 0.030 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2014 | 214 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2002 | 7849 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2017 | 1697 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1794 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5663 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2367 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2016 | 15476 | 0.030 |
Why?
|
Kidney Diseases | 1 | 1983 | 2093 | 0.020 |
Why?
|
Goals | 1 | 2017 | 711 | 0.020 |
Why?
|
Morbidity | 1 | 2017 | 1750 | 0.020 |
Why?
|
Geriatrics | 1 | 2016 | 388 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2014 | 932 | 0.020 |
Why?
|
Aortic Valve | 1 | 2021 | 1960 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2007 | 4475 | 0.020 |
Why?
|
Pyridines | 1 | 1983 | 2868 | 0.020 |
Why?
|
Prosthesis-Related Infections | 1 | 2016 | 488 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2012 | 352 | 0.020 |
Why?
|
Prevalence | 2 | 2010 | 15698 | 0.020 |
Why?
|
Assisted Circulation | 1 | 2011 | 100 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3134 | 0.020 |
Why?
|
Models, Animal | 1 | 2017 | 2111 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 1998 | 2205 | 0.020 |
Why?
|
Depressive Disorder | 1 | 1983 | 3728 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1069 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 1999 | 1418 | 0.020 |
Why?
|
Residence Characteristics | 2 | 2010 | 2087 | 0.020 |
Why?
|
Body Mass Index | 1 | 2007 | 12932 | 0.020 |
Why?
|
Chi-Square Distribution | 2 | 2010 | 3418 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2019 | 2163 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2016 | 2425 | 0.020 |
Why?
|
Medical Informatics | 1 | 2016 | 733 | 0.020 |
Why?
|
Risk | 2 | 2011 | 9605 | 0.020 |
Why?
|
Developmental Disabilities | 1 | 2017 | 1508 | 0.020 |
Why?
|
Program Evaluation | 1 | 2017 | 2493 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 7996 | 0.020 |
Why?
|
Japan | 1 | 2012 | 1366 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2020 | 3088 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 1983 | 4226 | 0.020 |
Why?
|
Cell Line | 1 | 2002 | 15598 | 0.020 |
Why?
|
Gene Frequency | 1 | 2014 | 3637 | 0.020 |
Why?
|
Kidney | 1 | 1983 | 7046 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1571 | 0.020 |
Why?
|
Databases as Topic | 1 | 2009 | 473 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1998 | 4355 | 0.020 |
Why?
|
Mortality | 1 | 2018 | 2897 | 0.020 |
Why?
|
Data Collection | 1 | 2016 | 3321 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2017 | 2687 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2013 | 1859 | 0.020 |
Why?
|
Resource Allocation | 1 | 2009 | 350 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3876 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2007 | 151 | 0.020 |
Why?
|
Multiple Organ Failure | 1 | 2008 | 386 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10759 | 0.020 |
Why?
|
Zebrafish | 1 | 2017 | 3002 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3419 | 0.020 |
Why?
|
Hirudins | 1 | 2006 | 179 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 1807 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2501 | 0.020 |
Why?
|
Systole | 1 | 2007 | 937 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2852 | 0.010 |
Why?
|
Ultrasonography | 1 | 2017 | 5966 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 1991 | 20985 | 0.010 |
Why?
|
Thrombin | 1 | 2006 | 590 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8479 | 0.010 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1983 | 89 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4735 | 0.010 |
Why?
|
Cyclosporins | 1 | 1983 | 216 | 0.010 |
Why?
|
Methods | 1 | 1983 | 1074 | 0.010 |
Why?
|
Habits | 1 | 1983 | 147 | 0.010 |
Why?
|
Health Resources | 1 | 2009 | 935 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1998 | 18955 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2010 | 1436 | 0.010 |
Why?
|
Ultrasonics | 1 | 1983 | 207 | 0.010 |
Why?
|
Epilepsy | 1 | 2017 | 3286 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17639 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4849 | 0.010 |
Why?
|
Genomics | 1 | 2017 | 5806 | 0.010 |
Why?
|
Giant Cells | 1 | 2002 | 188 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16585 | 0.010 |
Why?
|
Central Venous Pressure | 1 | 2000 | 79 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1983 | 1627 | 0.010 |
Why?
|
Ventricular Remodeling | 1 | 2007 | 1264 | 0.010 |
Why?
|
Body Constitution | 1 | 2000 | 273 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2015 | 58859 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2016 | 4789 | 0.010 |
Why?
|
Heart Arrest, Induced | 1 | 2000 | 358 | 0.010 |
Why?
|
Animals | 5 | 2017 | 168253 | 0.010 |
Why?
|
Dogs | 1 | 1983 | 3839 | 0.010 |
Why?
|
Cardiac Output | 1 | 2000 | 837 | 0.010 |
Why?
|
Sheep | 1 | 2000 | 1440 | 0.010 |
Why?
|
Peroxidase | 1 | 2000 | 610 | 0.010 |
Why?
|
Exercise Tolerance | 1 | 2002 | 835 | 0.010 |
Why?
|
Syndrome | 1 | 1983 | 3267 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6525 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2000 | 916 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1999 | 1230 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1983 | 1299 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2476 | 0.010 |
Why?
|
Software | 1 | 2010 | 4426 | 0.010 |
Why?
|
Posture | 1 | 1999 | 955 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2006 | 6813 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 2000 | 1516 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 1999 | 1737 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 2004 | 1488 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2000 | 2676 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2001 | 1165 | 0.010 |
Why?
|
Comorbidity | 1 | 2009 | 10494 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 1983 | 2171 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2009 | 3996 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7230 | 0.010 |
Why?
|
Prostheses and Implants | 1 | 2000 | 1272 | 0.010 |
Why?
|
Heart Atria | 1 | 1999 | 1347 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10180 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2007 | 12320 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 30025 | 0.010 |
Why?
|
Thrombosis | 1 | 2006 | 2940 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2000 | 2683 | 0.010 |
Why?
|
Radiography | 1 | 1983 | 6963 | 0.010 |
Why?
|
Pedigree | 1 | 1999 | 4586 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2012 | 11453 | 0.010 |
Why?
|
Recurrence | 1 | 2004 | 8466 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4630 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 1983 | 2462 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 1998 | 36362 | 0.010 |
Why?
|
Models, Molecular | 1 | 1999 | 5427 | 0.010 |
Why?
|
Oxygen | 1 | 2000 | 4222 | 0.000 |
Why?
|
Child Development | 1 | 2000 | 2302 | 0.000 |
Why?
|
Neutrophils | 1 | 2000 | 3764 | 0.000 |
Why?
|
Rats | 1 | 1983 | 23712 | 0.000 |
Why?
|
Health Status | 1 | 2000 | 4071 | 0.000 |
Why?
|
Cognition | 1 | 1983 | 6973 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1983 | 10188 | 0.000 |
Why?
|
Genetic Variation | 1 | 1999 | 6570 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1983 | 18216 | 0.000 |
Why?
|